BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17390065)

  • 1. The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis.
    Okano J; Nagahara T; Matsumoto K; Murawaki Y
    Oncol Rep; 2007 May; 17(5):1195-200. PubMed ID: 17390065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
    Matsumoto K; Okano J; Nagahara T; Murawaki Y
    Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
    Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
    Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.
    Okano J; Nagahara T; Matsumoto K; Murawaki Y
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):543-51. PubMed ID: 18346049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
    Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.
    Sutter AP; Maaser K; Höpfner M; Huether A; Schuppan D; Scherübl H
    J Hepatol; 2005 Nov; 43(5):808-16. PubMed ID: 16083991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells.
    Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Wanebo H; Kouttab N; Chu W; Wan Y
    Oncol Rep; 2006 Oct; 16(4):907-13. PubMed ID: 16969513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
    Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
    Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.
    Liang RR; Zhang S; Qi JA; Wang ZD; Li J; Liu PJ; Huang C; Le XF; Yang J; Li ZF
    Int J Oncol; 2012 Sep; 41(3):969-78. PubMed ID: 22684543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
    Chun E; Lee KY
    Biochem Biophys Res Commun; 2004 Mar; 315(3):771-9. PubMed ID: 14975768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.
    Dziadyk JM; Sui M; Zhu X; Fan W
    Anticancer Res; 2004; 24(1):27-36. PubMed ID: 15015572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells.
    Suyama H; Igishi T; Sano H; Matsumoto S; Shigeoka Y; Nakanishi H; Endo M; Burioka N; Hitsuda Y; Shimizu E
    Int J Oncol; 2004 Jun; 24(6):1499-504. PubMed ID: 15138593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK.
    Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY
    Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel induces apoptosis via caspase-3 activation in human osteogenic sarcoma cells (U-2 OS).
    Lu KH; Lue KH; Chou MC; Chung JG
    J Orthop Res; 2005 Sep; 23(5):988-94. PubMed ID: 16140185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
    Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
    Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.